InsiderClue
← All stocks

Heartflow, Inc.

HTFL Scheduled selling only
CIK 0001464521 #1501 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$8.78M
$8.40M on a plan · $380.10K straight out of an exercise
Sold at will
$0.00
0 of 11 sales
Net
−$8.78M
$0.00 against sales at will

By person

11 insiders · 11 transactions
24.8×

John C.M. Farquhar holds 24.8 times base salary in stock. $16.10M of shares against $647.97K in salary for 2025.

Salary from the company's own proxy. The shares are what John C.M. Farquhar last reported holding, valued at $50.01, the price Common Stock. was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Farquhar John C.M.
Chief Executive Officer
—
$4.65M (4) scheduled
−$4.65M
321,914
0.3702%
$16.10M
−13.8%
Verghese Vikram
Chief Financial Officer
—
$3.75M (6) scheduled
−$3.75M
179,528
0.2065%
$8.98M
+56.4%
Rogers Campbell
Chief Medical Officer
—
$380.10K (1) scheduled
−$380.10K
86,459
0.0994%
$4.32M
—
Bain Capital Life Sciences Investors, LLC entity
10% owner
—
—
—
8,448,158
9.72%
$422.51M
—
Lightcap Jeffrey C
Director
—
—
—
4,909,223
5.65%
$245.52M
—
WELDON WILLIAM C
Director
—
—
—
243,931
0.2805%
$12.20M
+333.5%
BARABE TIMOTHY C
Director
—
—
—
188,231
0.2165%
$9.41M
+411.8%
Tansey Casey M
Director
—
—
—
114,750
0.1320%
$5.74M
—
Jones Marie L.
Chief Accounting Officer
—
—
—
32,176
0.0370%
$1.61M
—
Cullivan Julie A
Director
—
—
—
27,291
0.0314%
$1.36M
−38.6%
HealthCor Partners Management LP entity
Director
—
—
—
0
0.0000%
$0.00
—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 8
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 9,219
History held since 11 Aug 2025